Bayer Articles
Stock Commentary - Europe - week to Jan 28, 2008
4 February 2008
IFPMA increases assistance to WHO-based TDR program
4 February 2008
Xanthus' oral fludarabine NDA accepted by FDA
4 February 2008
FDA OKs Banner's nimodipine caps
4 February 2008
Bayer Schering Pharma plans 20M euro French HQ
28 January 2008
Bayer announces Michael Schade as new head of communications
28 January 2008
Stock Commentary - Europe - week to Jan 21, 2008
28 January 2008
Recothrom approved by the FDA
28 January 2008
Stock Commentary - Europe - week to Jan 14, 2008
21 January 2008
Novartis closes Japan research unit
21 January 2008
France's pharmacists concern over drug costs
21 January 2008
German drug price fixing penalties
21 January 2008
More NCEs added to Japan's NHI reimbursement list late December
14 January 2008
US Public Citizen group sues the FDA over antibiotics warnings
14 January 2008
Bayer's MabCampath cleared for CLL by EC
14 January 2008
Stock Commentary - Europe - week to January 7, 2008
7 January 2008
China's largest pharmacy chain signs 16 drug firms
24 December 2007
Bayer AG
17 December 2007
Stock Commentary - Europe - week to Dec 10, 2007
17 December 2007
Zevalin boosts PFS in follicular lymphoma
17 December 2007
Rivaroxaban cuts VTE risk in RECORD-1 trial
17 December 2007
Bayer seeks more health acquisitons
10 December 2007
Bayer submits new oral combo contraceptive
10 December 2007
Novartis signs 10-year Ab drug R&D alliance with MorphoSys potentially worth up to $1.0B
10 December 2007
EMEA suspends use of aprotinin drugs
3 December 2007
Stock Commentary - Europe - week to Nov 26, 2007
3 December 2007
EAEPC attacks EAASM as "sheer propaganda tool"
3 December 2007
Call for EU review of parallel trade by EAASM
26 November 2007
EFPIA chief speaks out at Lisbon meeting on drug innovation
26 November 2007
FDA OKs Nexavar for unresectable HCC
26 November 2007
Nexavar launched in UK for HCC
21 November 2007
Bayer temporarily stops Trasylol marketing
21 November 2007
Stock Commentary - Europe - week to Nov 12, 2007
19 November 2007
PH III Xarelto data to be presented at ASH
19 November 2007
Watson files ANDA for generic of Bayer-Schering's Yaz
19 November 2007
German drug discounts facing legal hurdles
19 November 2007
Reverse payment ban stalls in US Congress
19 November 2007
USA's HealthTrust signs 3-year renewal for Bayer's Magnevist
19 November 2007
Betaseron linked to fewer injection site reactions
12 November 2007
Indevus submits NDA for Nebido to US FDA
12 November 2007
New Trasylol warnings after BART study deaths
5 November 2007
Bayer submits Xarelto for VTE to EMEA
5 November 2007
Stock Commentary - Europe - week to Oct 29, 2007
5 November 2007
France
5 November 2007
EC clears Bayer/Onyx' Nexavar in HCC
5 November 2007
500mcg Betaferon fails to show result in RRMS
5 November 2007
Court rules for Bayer on Avelox patents
5 November 2007
Stock Commentary - Europe - week to October 22, 2007
29 October 2007
CHMP advocates MabCampath approval
29 October 2007
Stock Commentary - Europe - week to October 15, 2007
22 October 2007
Bayer/J&J's Xarelto will drive anticoagulant market
22 October 2007
Abraxis gains two FDA OKs for fludarabine
22 October 2007
Alemtuzumab cuts relapse risk in RRMS
22 October 2007
Bayer accused of pharma price-fixing
22 October 2007
Point Therapeutics to merge with DARA BioSci
22 October 2007
Stock Commentary - Europe - week to Oct 8, 2007
15 October 2007
Stock Commentary - Europe - week to Oct 1, 2007
8 October 2007
VEGF Trap-Eye reduces AMD retinal thickness
8 October 2007
Genzyme/Bayer start Ph III alemtuzumab program
1 October 2007
Europe leads surge in Pharma M&A deal values
1 October 2007
CHMP backs Bayer Schering's Nexavar
1 October 2007
FDA approves Campath as single agent for B-CLL
1 October 2007
Lilly Japan moves into GP market with Cialis
1 October 2007
Klaus Dembowsky named head of Speedel Experimenta
27 September 2007
Stock Commentary - Europe - week to September 24, 2007
27 September 2007
FDA clears new indication for Ortho-McNeil's Levaquin
24 September 2007
Bayer and Novartis biologics deal closes
24 September 2007
NCCN updates hepatobiliary cancer guidelines, adding Nexavar
17 September 2007
CRDAC recommends FDA OK for Trasylol
17 September 2007
Stock Commentary - Europe - week to Sept 10, 2007
17 September 2007
Bayer AG plans to delist from NYSE
10 September 2007
Bayer and Dyax accord on therapeutic antibodies
10 September 2007
Bayer to examine benefits of Aspirin in CVD
10 September 2007
German drug sales set to decline, VFA warns
3 September 2007
FDA accepts Nexavar HCC sNDA for review
3 September 2007
Stock Commentary - Europe - week to August 27, 2007
3 September 2007
Pfizer and B-MS finalize DGAT-1 collaboration
3 September 2007
Nexavar to be given to all patients in Asia-Pacific trial after it boosts survival in HCC
3 September 2007
Medtronic and Bayer to sell glucose meter outside USA
3 September 2007
Bayer did not withhold Trasylol safety data
3 September 2007
Cell Therapeutics buys Zevalin from Biogen Idec for $10M, with up to $20M extra plus milestones
3 September 2007
Bayer shares jump 7.3% on Novartis takeover speculation
20 August 2007
Stock Commentary - Europe - week to Aug 13, 2007
20 August 2007
Competition in the venous thromboembolism market
20 August 2007
Regeneron gets $20M milestone from Bayer
20 August 2007
Domestic vs JV drug prices in China differ
20 August 2007
Health Canada approves GW/Bayer's Sativex for cancer pain
13 August 2007
Bayer and Nektar sign pneumonia drug accord
13 August 2007
Early Betaferon use cuts MS disability risk
13 August 2007
Bayer/Regeneron begin Ph III Trap-Eye study
13 August 2007
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
